Kidney stone disease (KSD) is a significant pathology in clinical practice. One of the most important causes of stone formation are drugs. Drugs lead to drug-induced (DI) KSD by crystallization in the urine and influence on various metabolic processes. Among the drugs capable of crystallization, it is necessary to note antibacterial drugs. KSD inducers from this group include aminopenicillins, quinolones and ceftriaxone. The most important risk factor for nephrolithiasis while taking antibacterial drugs is their use in high doses. In addition to drugs that crystallize in the urine, drugs that affect various metabolic processes play an important role as inducers of KSD. These include calcium supplements, vitamin D and C supplements, and carbonic anhydrase inhibitors. The role of the mentioned additives as inducers of urolithiasis can be underestimated due to their widespread use, including without a doctor’s prescription. Pediatric practice also describes the processes of stone formation against the background of the use of furosemide. It is also necessary to note allopurinol, the mechanism of lithogenesis against the background of which is mixed. The uniqueness of this review is that data on inducer drugs were combined from various sources and structured according to a single plan.

Keywords: drug-induced kidney stone disease, vitamin C, kidney stone disease, adverse drug reactions, antibacterial drugs, vitamin D, drugs, allopurinol